Clinical Trials in Arizona

Showing 16681-16700 of 16,770 trials

Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

NCT00043797

This clinical trial is to determine an effective dosage and to study the safety of an investigational drug -lidorestat (IDD-676)- which is intended to stop or slow the progression of diabetic peripheral neuropathy.

Diabetic Polyneuropathy

The Institute for Diabetes Discovery, LLC

Scottsdale, Arizona, United States • Glendale, California, United States • Greenbrae, California, United States +11 more locations

COMPLETEDPhase 2/342 miles

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.

NCT00055510

This research study is intended to evaluate the safety and effectiveness of 3 different doses of BO-653, an investigational inhibitor of LDL cholesterol oxidation, when given orally twice a day compared to placebo (an inactive substance) in preventing restenosis (closure of vessel) within six months after stent implantation. Patients must be enrolled into this study within 24 hours after the stenting procedure. Additionally, over a 1- to 9-month post-stent period, the study will compare the safety and effectiveness of BO-653 versus placebo for measures of coronary artery vessel size by quantitative coronary angiography, major adverse cardiac events, and effects on the oxidative status of plasma lipids and other plasma components.

Graft Occlusion, VascularCoronary RestenosisAtherosclerosis

Chugai Pharma USA

Phoenix, Arizona, United States • Tucson, Arizona, United States • Burlingame, California, United States +26 more locations

Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.

Find Trials by Condition in Arizona

Trial of VLTS-589 in Subjects With Intermittent Claudication

A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients

A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient

A Study of 141W94 in Combination With Other Anti-HIV Drugs

A Study of Thymic Humoral Factor (THF Gamma 2) in HIV-Infected Patients

Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease

A Study to Compare Two Anti-HIV Drug Combinations

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma

An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children

A Study of T-20 in HIV-Positive Adults

A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

A Study of Timunox (Thymopentin) in HIV-Infected Patients Receiving Other Anti-HIV Drugs

The Metabolic Effects of Protease Inhibitors in HIV Infected Children

The Safety and Effectiveness of 935U83 in HIV-Infected Patients

Randomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's Sarcoma